文献速递精神分裂症与精神病性障碍心境障碍会诊联络精神医学

神经精神障碍中视网膜细胞类型的遗传学分析

Genetic Analysis of Retinal Cell Types in Neuropsychiatric Disorders.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

该遗传关联研究将精神分裂症、双相障碍、重性抑郁障碍、多发性硬化、帕金森病、阿尔茨海默病和卒中的全基因组关联研究结果与人类、猕猴和小鼠的视网膜单细胞转录组数据集相结合,发现无长突细胞表达谱在精神分裂症遗传风险中富集且主要由突触生物学基因驱动,视网膜免疫细胞群表达谱在多发性硬化遗传风险中富集,而在UK Biobank中精神分裂症多基因风险较高与神经节细胞内丛状层变薄相关。

要点

  • 无长突细胞表达谱在精神分裂症遗传风险中跨哺乳动物物种和不同发育阶段稳健富集。
  • 视网膜免疫细胞群表达谱在多发性硬化遗传风险中富集,其他疾病未发现一致的细胞类型关联。
  • 精神分裂症多基因风险较高与神经节细胞内丛状层变薄相关,多发性硬化多基因风险较高与视网膜神经纤维层增厚相关。

核心结论

  • 该研究为神经精神和神经系统疾病中视网膜改变的细胞基础提供了新见解,并强调视网膜可作为研究精神分裂症突触病理的潜在替代窗口。

研究设计与样本

  • 遗传关联研究,将精神分裂症、双相障碍、重性抑郁障碍、多发性硬化、帕金森病、阿尔茨海默病和卒中的全基因组关联研究结果与人类、猕猴和小鼠的视网膜单细胞转录组数据集相结合。
  • 采用Multi-Marker Analysis of Genomic Annotation(MAGMA)细胞类型富集分析识别易感细胞类型,并进行后续通路分析。
  • 将细胞层面顶级命中结果利用UK Biobank大型人群队列中2009年至2010年采集的视网膜光学相干断层扫描和基因分型数据转化至结构层面;数据分析于2022年至2024年间进行。

主要发现

  • 无长突细胞(视网膜内中间神经元)表达谱在精神分裂症遗传风险中跨哺乳动物物种和不同发育阶段稳健富集,该富集主要由参与突触生物学的基因驱动。
  • 视网膜免疫细胞群表达谱在多发性硬化遗传风险中富集;双相障碍、重性抑郁障碍、帕金森病、阿尔茨海默病或卒中未发现一致的细胞类型关联。
  • 在结构层面,精神分裂症多基因风险较高与神经节细胞内丛状层(含无长突细胞树突和突触连接)变薄相关(B,-0.09;95%CI,-0.16至-0.03;P=.007;n=36349;平均[SD]年龄57.50[8.00]岁;女性19859例[54.63%])。
  • 多发性硬化多基因风险较高与视网膜神经纤维层厚度增加相关(B,0.06;95%CI,0.02至0.10;P=.007;n=36371;平均[SD]年龄57.51[8.00]岁;女性19843例[54.56%])。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: As an accessible part of the central nervous system, the retina provides a unique window to study pathophysiological mechanisms of brain disorders in humans. Imaging and electrophysiological studies have revealed retinal alterations across several neuropsychiatric and neurological disorders, but it remains largely unclear which specific cell types and biological mechanisms are involved. OBJECTIVE: To determine whether specific retinal cell types are affected by genomic risk for neuropsychiatric and neurological disorders and to explore the mechanisms through which genomic risk converges in these cell types. DESIGN, SETTING, AND PARTICIPANTS: This genetic association study combined findings from genome-wide association studies in schizophrenia, bipolar disorder, major depressive disorder, multiple sclerosis, Parkinson disease, Alzheimer disease, and stroke with retinal single-cell transcriptomic datasets from humans, macaques, and mice. To identify susceptible cell types, Multi-Marker Analysis of Genomic Annotation (MAGMA) cell-type enrichment analyses were applied and subsequent pathway analyses performed. The cellular top hits were translated to the structural level using retinal optical coherence tomography (acquired between 2009 and 2010) and genotyping data in the large population-based UK Biobank cohort study. Data analysis was conducted between 2022 and 2024. MAIN OUTCOMES AND MEASURES: Cell type-specific enrichment of genetic risk loading for neuropsychiatric and neurological disorder traits in the gene expression profiles of retinal cells. RESULTS: Expression profiles of amacrine cells (interneurons within the retina) were robustly enriched in schizophrenia genetic risk across mammalian species and in different developmental stages. This enrichment was primarily driven by genes involved in synapse biology. Moreover, expression profiles of retinal immune cell populations were enriched in multiple sclerosis genetic risk. No consistent cell-type associations were found for bipolar disorder, major depressive disorder, Parkinson disease, Alzheimer disease, or stroke. On the structural level, higher polygenic risk for schizophrenia was associated with thinning of the ganglion cell inner plexiform layer, which contains dendrites and synaptic connections of amacrine cells (B, -0.09; 95% CI, -0.16 to -0.03; P = .007; n = 36 349; mean [SD] age, 57.50 [8.00] years; 19 859 female [54.63%]). Higher polygenic risk for multiple sclerosis was associated with increased thickness of the retinal nerve fiber layer (B, 0.06; 95% CI, 0.02 to 0.10; P = .007; n = 36 371; mean [SD] age, 57.51 [8.00] years; 19 843 female [54.56%]). CONCLUSIONS AND RELEVANCE: This study provides novel insights into the cellular underpinnings of retinal alterations in neuropsychiatric and neurological disorders and highlights the retina as a potential proxy to study synaptic pathology in schizophrenia.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Boudriot E, Stephan M, Rabe F, et al. Genetic Analysis of Retinal Cell Types in Neuropsychiatric Disorders. JAMA Psychiatry. 2025. PMID: 39775833. doi:10.1001/jamapsychiatry.2024.4230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。